Nonclinical Development Program - Our Development Approach
-
1. Objective Definition
Our mission is to deliver a superior vaping experience that combines flavor, satisfaction, and safety. The Lula device and Chosen e-Liquid pods are developed to provide optimal nicotine delivery while ensuring a smooth and enjoyable experience.
-
2. Product Characterization
LULA Device Specifications:
The LULA vaping device features a sleek, ergonomic design that fits comfortably in hand and is simple to operate. Built with high-quality materials, it delivers reliable performance and durability, making it a trusted option for those seeking a consistent and user-friendly experience. Its advanced technology ensures smooth vapor delivery without the need for buttons or complicated settings, offering a seamless transition for users under therapeutic guidance.Chosen e-Liquid Composition:
CHOSEN e-liquids are expertly formulated using premium, pharmaceutical-grade ingredients. Each bottle delivers a carefully balanced blend designed to meet therapeutic standards while enhancing the vaping experience. With a range of well-developed flavors, CHOSEN e-liquid provide both satisfaction and consistency, supporting individuals on their journey to manage nicotine dependence. Manufactured to the highest safety and quality benchmarks, CHOSEN and LULA together represent a trusted, compliant solution for modern therapeutic vaping. -
3. Preclinical Testing
To prioritize safety, we conduct extensive preclinical testing that includes:
Toxicology Studies: Rigorous assessments to evaluate the safety of the aerosol produced by the Lula device and the Chosen e-Liquid.
Biocompatibility Assessments: Evaluating the safety of materials used in both the device, pods and e-liquid to ensure they are suitable for consumer use.
Pharmacokinetics Studies: Understanding how the active ingredients in our e-Liquid are absorbed and metabolized by the body.
-
4. Performance Testing
Our commitment to quality is reflected in our performance testing, which includes:
Aerosol Characterization: Analyzing aerosol properties, including particle size distribution and nicotine delivery efficiency.
User Experience Studies: Collecting feedback from users to assess satisfaction, usability, and overall experience with the Lula device and Chosen e-Liquid.
-
5. Stability Studies
We conduct stability studies to ensure that our Lula device and e-Liquid maintain their quality and performance over time, under various environmental conditions.
-
6. Regulatory Compliance
Bay Pharma is dedicated to meeting all regulatory requirements. Our comprehensive documentation demonstrates compliance, ensuring that our products are safe and effective for consumers.
-
7. Risk Assessment
We perform detailed risk assessments to identify potential hazards associated with our products and implement strategies to mitigate these risks, prioritizing consumer safety throughout the development
process -
8. Data Analysis and Reporting
Our development team compiles and analyzes data from all studies, generating detailed reports that inform our product development and support regulatory submissions
-
9. Stakeholder Engagement
We actively collaborate with healthcare professionals, regulatory agencies, and consumers to gather insights and feedback, continuously improving our products based on this valuable input.
-
Our Commitment to Quality
At Bay Pharma, quality and transparency are our core values. Our nonclinical development program reflects our commitment to providing safe, effective, and enjoyable vaping solutions that our customers can trust.
-
Stay Connected
For more information about our products, to learn more about our development initiatives, or to receive updates, please subscribe to our newsletter or contact us directly.